Literature DB >> 10614883

Clinical experience with a proximally porous-coated second-generation cementless total hip prosthesis: minimum 5-year follow-up.

M A Mont1, T R Yoon, K A Krackow, D S Hungerford.   

Abstract

This study reports the minimum 5-year follow-up of our experience with the Porous-Coated Anatomic E (PCA-E) series femoral stem and the modular acetabular cup. A total of 115 consecutive total hip replacements using PCA-E series (Howmedica, Rutherford, NJ) were performed in 108 patients. Six patients whose hips were performing well clinically died before 5-year follow-up and were excluded from the final evaluation. The remaining 109 hips (102 patients) were assessed at a mean follow-up of 72 months (range, 60-84 months). The hip diagnoses were osteoarthritis in 73, osteonecrosis in 31, rheumatoid arthritis in 2, and hip dysplasia in 3. The mean age was 56 years (range, 24-83 years). Three hips were revised: 1 because of late hematogenous infection, 1 because of aseptic loosening of the femoral component, and 1 because of postoperative loosening of an acetabular component. The Harris hip scores improved from a mean of 50 points (range, 20-66 points) preoperatively to a mean of 92 points (range, 64-100 points) at final follow-up. The score differed in each Charnley functional class, with a mean of 93 points (range, 72-100 points) in 57 hips of class A (no other joint involvement); 90 points (range, 58-100 points) in 26 hips of class B (opposite hip involvement); and 85 points (range, 37-100 points) in 26 hips of class C (multiple joint involvement or severe systemic disease). Out of 106 hips that had a full radiographic evaluation performed, 103 femoral components revealed stable bony ingrowth, 2 revealed stable fibrous ingrowth, and 1 showed migration with progressive loosening. This patient with radiographic loosening has minimal symptoms and has not required or been offered further surgery (Harris hip score of 86 points). The low aseptic loosening rate (2%) at minimum 5-year follow-up compares favorably with any cemented or cementless series. The osteolysis that was seen was focal and localized. The short follow-up does not allow determination of progression. There were no cases of distal osteolysis. We attribute the improved results from reported first-generation experience to multiple factors, including increased number of sizes (9 vs 6), increased proportional metaphyseal size, improved polyethylene manufacture (ram extruded vs machined), improved acetabular locking mechanism, and change to 26-mm from 32-mm femoral heads.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10614883     DOI: 10.1016/s0883-5403(99)90006-2

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  5 in total

1.  Mid-term results of 155 patients treated with a collum femoris preserving (CFP) short stem prosthesis.

Authors:  Daniel Briem; Michael Schneider; Nicole Bogner; Nadine Botha; Matthias Gebauer; Thorsten Gehrke; Bernd Schwantes
Journal:  Int Orthop       Date:  2010-05-02       Impact factor: 3.075

2.  Densitometric evaluation of periprosthetic bone remodeling.

Authors:  Paolo Domenico Parchi; Valentina Cervi; Nicola Piolanti; Gianluca Ciapini; Lorenzo Andreani; Iacopo Castellini; Andrea Poggetti; Michele Lisanti
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

3.  Partial weightbearing is not necessary after cementless total hip arthroplasty: a two-year prospective randomized study on 100 patients.

Authors:  Max Markmiller; Thomas Weiss; Peter Kreuz; Axel Rüter; Gerhard Konrad
Journal:  Int Orthop       Date:  2010-07-11       Impact factor: 3.075

4.  Excellent survivorship with the use of proximally coated tapered cementless stems for total hip arthroplasty in octogenarians.

Authors:  D Alex Stroh; Michael G Zywiel; Aaron J Johnson; Michael A Mont
Journal:  Geriatr Orthop Surg Rehabil       Date:  2011-05

5.  Short stems have lower load at failure than double-wedged stems in a cadaveric cementless fracture model.

Authors:  Antonio Klasan; Martin Bäumlein; Philipp Dworschak; Christopher Bliemel; Thomas Neri; Markus D Schofer; Thomas J Heyse
Journal:  Bone Joint Res       Date:  2019-11-02       Impact factor: 5.853

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.